President Trump today touted “bold” plans to lower drug prices in unspecific terms. Simultaneously, CMS issued an Advance Notice of Proposed Rulemaking (ANRPM), describing options to test Medicare reimbursement based on an “International Pricing Index” (IPI), under which U.S. drug prices would be benchmarked against 16 other countries that reportedly have lower drug
Latest Post
More Posts
CMS proposes requiring drug prices in TV ads
HHS: Qualified Health Plans are Not “Federal Health Care Programs”
Medicare Inpatient Hospital Final Rule for Fiscal Year 2014 Released; Includes Changes to Inpatient Admission and Rebilling Policies
CMS Issues New Notice on Its National Coverage Determination Process
CMS Releases Physician Fee Schedule and Hospital Outpatient/Ambulatory Surgical Center Proposed Rules for Calendar Year 2014
Medicare Inpatient Hospital Proposed Rule for Fiscal Year 2014 Released
Obama Releases Budget Proposal
CMS Innovation Center Launches New Medicare ESRD Shared Savings Program
Going Over the Overpayment Cliff
Subscribe: Subscribe via RSS
Blogs
Firm/Org